Status
Conditions
Study type
Funder types
Identifiers
About
The purpose of this study is to evaluate the percentage of moderate to severe IBD participants with active disease at Day 1.
Full description
This is a retrospective, cross-sectional, and non-interventional study of participants with IBD. The study will have a cross-sectional evaluation on Day 1 to provide the real-world data of disease activity, treatment patterns, burden of disease and quality of life in participants with moderate to severe CD or UC.
The study will involve an additional retrospective review of medical charts of participants of previous 3 years to describe the IBD treatments and use of other healthcare resources related with management of IBD.
The study will enroll approximately 246 participants. All participants will be enrolled in one observational cohort.
This multi-center trial will be conducted in Argentina. The overall time for data collection in the study will be approximately 3 years before the start of the study (Day 1).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
246 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal